ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,622 | -35.1% | 24,450 | 0.0% | 0.00% | – |
| Q1 2023 | $8,664 | +9.2% | 24,450 | 0.0% | 0.00% | – |
| Q4 2022 | $7,935 | +296.8% | 24,450 | +760.9% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 2,840 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -84.2% | 2,840 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | +216.7% | 2,840 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -40.0% | 2,840 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -37.5% | 2,840 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -76.1% | 2,840 | -78.0% | 0.00% | – |
| Q1 2021 | $67,000 | +3250.0% | 12,890 | +1135.9% | 0.00% | – |
| Q4 2020 | $2,000 | – | 1,043 | +216.1% | 0.00% | – |
| Q3 2020 | $0 | – | 330 | +17.9% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 280 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |